SCHEMBL4436048

SCHEMBL4436048

CC(C)(C)OC(=O)N(c1ccncc1N)[C@@H]1CCCNC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPLP1 P05386 12/20 0.36
RPLP0 P05388 12/20 0.36
RPS17 P08708 12/20 0.36
RPSA P08865 12/20 0.36
RPS2 P15880 12/20 0.36
RPL35A P18077 12/20 0.36
RPL7 P18124 12/20 0.36
RPL17 P18621 12/20 0.36
RPS4Y1 P22090 12/20 0.36
RPS3 P23396 12/20 0.36
RPS12 P25398 12/20 0.36
RPL13 P26373 12/20 0.36
RPL10 P27635 12/20 0.36
RPL12 P30050 12/20 0.36
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 12/20 0.36
RPL22 P35268 12/20 0.36
RPL4 P36578 12/20 0.36
RPS19 P39019 12/20 0.36
RPL3 P39023 12/20 0.36
RPL13A P40429 12/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3410672 1.00 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410670 1.00 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4439873 0.94 SLC6A4 (0.36) KCNH2
SCHEMBL4445128 0.92 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3412017 0.84 RPLP1 (0.41) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3412292 0.84 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3412297 0.84 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4443619 0.84 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL1710277 0.83 NAMPT (0.33) PCSK9
SCHEMBL4443673 0.82 RPLP1 (0.34) RPLP1RPLP0RPS17RPSARPS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed